Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
Opinion and Comment
Nature Biotechnology 24, 1512–1514 (1 December 2006) | doi:10.1038/nbt1206-1512
Antibiotics|[mdash]|an investment worth making?
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
